{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T04:11:30Z","timestamp":1750824690844,"version":"3.41.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.prp.2017.07.028","type":"journal-article","created":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T18:33:05Z","timestamp":1501612385000},"page":"1067-1071","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Evaluation of expression of genes CADM1, TWIST1 and CDH1 by immunohistochemestry in melanocytic lesions"],"prefix":"10.1016","volume":"213","author":[{"given":"Karina","family":"Munhoz de Paula Alves Coelho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaqueline","family":"Stall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herc\u00edlio","family":"Fronza J\u00fanior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo","family":"Blasius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo Henrique Condeixa","family":"de Fran\u00e7a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.prp.2017.07.028_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0045037","article-title":"Novel multiple markers to distinguish melanoma from dysplastic nevi","volume":"7","author":"Zhang","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.prp.2017.07.028_bib0010","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00428-014-1570-1","article-title":"Cell cycle analysis can differentiate thin melanomas from dysplastic nevi and reveals accelerated replication in thick melanomas","volume":"464","author":"Kiszner","year":"2014","journal-title":"Virchows Arch."},{"issue":"5","key":"10.1016\/j.prp.2017.07.028_bib0015","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.suc.2014.07.013","article-title":"Epidemiology, risk factors, prevention, and early detection of melanoma","volume":"94","author":"Azoury","year":"2014","journal-title":"Surg. Clin. North Am."},{"key":"10.1016\/j.prp.2017.07.028_bib0020","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s12967-015-0570-5","article-title":"MiR-21: an environmental driver of malignant melanoma?","volume":"13","author":"Melnik","year":"2015","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.prp.2017.07.028_bib0025","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s13000-015-0431-9","article-title":"A p16-Ki-67-HMB45 immunohistochemistry scoring system as an ancillary diagnostic tool in the diagnosis of melanoma","volume":"10","author":"Uguen","year":"2015","journal-title":"Diagn. Pathol."},{"issue":"4","key":"10.1016\/j.prp.2017.07.028_bib0030","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1053\/j.semdp.2013.11.002","article-title":"Molecular pathology of melanocytic tumors","volume":"30","author":"Busam","year":"2013","journal-title":"Semin. Diagn. Pathol."},{"issue":"6","key":"10.1016\/j.prp.2017.07.028_bib0035","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/CMR.0b013e328358d9a2","article-title":"TSLC1 expression discriminates cutaneous melanomas from dysplastic nevi","volume":"22","author":"You","year":"2012","journal-title":"Melanoma Res."},{"issue":"Suppl. 15","key":"10.1016\/j.prp.2017.07.028_bib0040","article-title":"CADM1 is a TWIST1 regulated supressor of melanoma invasion [abstract]","volume":"75","author":"Hartsough","year":"2015","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.prp.2017.07.028_bib0045","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1007\/s13277-013-1002-x","article-title":"Twist: a molecular target in cancer therapeutics","volume":"34","author":"Khan","year":"2013","journal-title":"Tumour Biol."},{"issue":"1","key":"10.1016\/j.prp.2017.07.028_bib0050","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s12094-016-1555-4","article-title":"Differential BMI1, TWIST1, SNAI2 mRNA expression pattern correlation with malignancy type in a spectrum of common cutaneous malignancies: basal cell carcinoma, squamous cell carcinoma, and melanoma","volume":"19","author":"Vand-Rajabpour","year":"2017","journal-title":"Clin. Transl. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2017.07.028_bib0055","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.stem.2014.12.002","article-title":"Different levels of Twist1 regulate skin tumor initiation, stemness, and progression","volume":"16","author":"Beck","year":"2015","journal-title":"Cell Stem Cell"},{"issue":"4","key":"10.1016\/j.prp.2017.07.028_bib0060","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1586\/17469872.2.4.451","article-title":"Mechanism of UV-related carcinogenesis and its contribution to nevi\/melanoma","volume":"2","author":"Anna","year":"2007","journal-title":"Expert Rev. Dermatol."},{"issue":"1","key":"10.1016\/j.prp.2017.07.028_bib0065","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.3892\/or.2016.4618","article-title":"DNA methylation-induced E-cadherin silencing is correlated with the clinicopathological features of melanoma","volume":"35","author":"Venza","year":"2016","journal-title":"Oncol. Rep."},{"issue":"5","key":"10.1016\/j.prp.2017.07.028_bib0070","first-page":"360","article-title":"Understanding interobserver agreement: the Kappa statistic","volume":"37","author":"Viera","year":"2005","journal-title":"Fam. Med."},{"year":"2012","series-title":"MicroRNA-205 Involvement in Cutaneous Melanoma","author":"Rees","key":"10.1016\/j.prp.2017.07.028_bib0075"},{"issue":"3","key":"10.1016\/j.prp.2017.07.028_bib0080","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/CMR.0b013e32833413c0","article-title":"TSLC1 gene silencing in cutaneous melanoma","volume":"20","author":"You","year":"2010","journal-title":"Melanoma Res."},{"issue":"5","key":"10.1016\/j.prp.2017.07.028_bib0085","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.3892\/mmr.2014.2556","article-title":"CADM1\/TSLC1 inhibits melanoma cell line A375 invasion through the suppression of matrix metalloproteinases","volume":"10","author":"You","year":"2014","journal-title":"Mol. Med. Rep."},{"issue":"15","key":"10.1016\/j.prp.2017.07.028_bib0090","doi-asserted-by":"crossref","first-page":"5270","DOI":"10.1158\/0008-5472.CAN-04-0731","article-title":"Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas expression profiling reveals novel pathways in the transformation of melanocytes to melanomas","volume":"64","author":"Hoek","year":"2004","journal-title":"Cancer Res."},{"year":"2013","series-title":"Development of Malignant Melanoma Is Dependent on a Switch in Embryonic Transcription Factors Orchestrated by the BRAF-MAPK Pathway","author":"Papadogeorgakis","key":"10.1016\/j.prp.2017.07.028_bib0095"},{"issue":"1","key":"10.1016\/j.prp.2017.07.028_bib0100","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ccr.2008.06.005","article-title":"Induction of EMT by Twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence","volume":"14","author":"Ansieau","year":"2008","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.prp.2017.07.028_bib0105","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/jid.2012.474","article-title":"Mutant BRAF: a novel mediator of microenvironmental escape in melanoma?","volume":"133","author":"Smalley","year":"2013","journal-title":"J. Invest. Dermatol."},{"issue":"4","key":"10.1016\/j.prp.2017.07.028_bib0110","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ccr.2013.08.018","article-title":"A switch in the expression of embryonic emt-inducers drives the development of malignant melanoma","volume":"24","author":"Caramel","year":"2013","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.prp.2017.07.028_bib0115","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1590\/S1676-24442010000200007","article-title":"Immunohistochemical assessment of E-cadherin, \u03b2-catenin, CEACAM-1 and PTEN: tumor progression markers in melanoma","volume":"46","author":"Jung","year":"2010","journal-title":"J. Bras. Patol. Med. Lab."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033817301346?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033817301346?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T19:49:48Z","timestamp":1750794588000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033817301346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":23,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S0344033817301346"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2017.07.028","relation":{},"ISSN":["0344-0338"],"issn-type":[{"type":"print","value":"0344-0338"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of expression of genes CADM1, TWIST1 and CDH1 by immunohistochemestry in melanocytic lesions","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2017.07.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}